Provider review
Vytora Health review
Prints the block total beside the divided figure, which almost nothing else here does.
Its own footnote concedes prices may vary by dosage, without publishing a single rung to check that against.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Vytora Health
$179/mo sema · $249/mo tirz month-to-month
- Vs median
- $10/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The presentation here is better than the prices, and the prices are unremarkable in a good way — mid-range for both molecules, month to month, with the medication and the clinical care and the shipping stated to be inside the figure rather than billed beside it. What stands out is the three-month option. Nearly every seller offering a discounted block quotes it as a per-month figure and leaves the reader to discover the size of the actual charge at checkout, which is how a twelve-month prepay ends up advertised as an eighty-dollar month. Vytora prints both numbers together. You can see what the block costs, decide whether you want to commit that much before knowing how you respond to the drug, and do it with the arithmetic already done for you. That is a small piece of honesty and it is rare enough to be the main reason to look here. The gap is the same one almost everywhere: no milligram is attached to anything. The footnote goes further than most by conceding that actual prices may vary by dosage, which is an admission that the published figure is not the whole story without saying what the rest of the story is. So you can budget the plan and cannot check whether the dose you intend to hold is the dose the figure was set for.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are weighing a discounted block and want to see the real charge before committing
- You want a month-to-month rate published rather than only a multi-month price
- You want the medication, the clinician and the supplies inside one figure
Look elsewhere if
- You want a price tied to a dose. Nothing here attaches a milligram to a figure
- You want a firm number. Its own footnote says prices may vary by dosage
- You want the pharmacy named. They are described as licensed and U.S.-based only
What it actually costs
Price as published
Compounded semaglutide at $179/mo and compounded tirzepatide at $249/mo on the month-to-month plan, described as all-inclusive of medication, physician care, supplies, shipping and follow-ups with no membership · ★★ the three-month option is presented honestly: it quotes $149/mo AND states the charge beside it — billed $447 — so a reader can see the sum they are actually charged rather than only the average it works out to, which is the single commonest omission in this category · branded Mounjaro is priced at $1,399/mo and labeled month-to-month · NAD+ and sermorelin are sold alongside at $249/mo and $199/mo · no dose sits behind any figure, and the site's own footnote concedes that "actual prices may vary by dosage and treatment", which is the closest thing to a statement that the price moves with the dose without saying how · dose escalation is described as clinician-led with unlimited provider follow-ups, and pharmacies are stated to be licensed and U.S.-based without being named
- Vs median
- $10/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★★ The three-month option prints the actual charge beside the per-month figure, which is the single commonest omission in this category — nearly every discounted block here is quoted as a monthly average and the size of the real charge is discovered at checkout. A reader can therefore decide whether to commit before knowing how they respond to the drug, with the arithmetic already done. Both molecules carry a month-to-month rate too, stated as all-inclusive with no membership. No dose sits behind any figure and the footnote concedes prices may vary by dosage without saying how, so the published number cannot be checked against the dose a reader intends to hold. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The three-month option states the actual charge beside the per-month figure.
- Medication, physician care, supplies and shipping are stated to be inside one price.
- The month-to-month plan is available at a published rate rather than only a block.
Pharmacy, labs and oversight
Vytora Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Vytora Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The presentation here is better than the prices, and the prices are unremarkable in a good way — mid-range for both molecules, month to month, with the medication and the clinical care and the shipping stated to be inside the figure rather than billed beside it. What stands out is the three-month option. Nearly every seller here that offers a discounted block quotes it as a per-month figure and leaves the reader to discover the size of the actual charge at checkout, which is how a twelve-month prepay ends up advertised as an eighty-dollar month. Vytora prints both numbers together. A reader can see what the block costs, decide whether they want to commit that much before knowing how they respond to the drug, and do so with the arithmetic already done for them. That is a small piece of honesty and it is rare enough to be the main reason to look here. The gap is the same one almost everywhere: no milligram is attached to anything. The footnote goes further than most by conceding that actual prices may vary by dosage, which is an admission that the published figure is not the whole story without saying what the rest of the story is. So a reader can budget the plan but cannot check whether the dose they intend to hold is the dose the figure was set for.
The honest cons
No dose sits behind any figure, so nothing can be matched to an amount of drug.
- Its own footnote concedes prices may vary by dosage without saying how.
- The pharmacies are described as licensed and U.S.-based but are not named.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Vytora Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#240 of 373
Ordered with the companies that pay us first, and Vytora Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.